ALA survey identifies gaps in lung cancer awareness

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The American Lung Association’s LUNG FORCE initiative released the 2021 Lung Health Barometer, a national survey that examines awareness, attitudes, and beliefs about lung health and lung cancer. This is the sixth year the survey has been conducted.

The 2021 Lung Health Barometer surveyed 4,000 Americans nationwide about lung health and lung cancer. Some key findings include:

  • 29% of Americans know that lung cancer is the leading cancer killer of women and men, an 8% increase from the 2020 Lung Health Barometer.
  • 10% of adults understand that lung cancer is among the most likely cancers to affect women while 35% know that it is among those likely to affect men.
  • 36% of respondents know that lung cancer screening is now available for early detection of the disease.

More results from the Lung Health Barometer survey can be found here.

Table of Contents

YOU MAY BE INTERESTED IN

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings.
At the 2026 Annual Meeting of the American Society of Clinical Oncology in Chicago, results from the phase III HARMONi-6 trial were presented at the plenary session and published simultaneously in The Lancet. The HARMONi-6 trial tested a novel bispecific antibody that engages PD-1 and VEGF (ivonescimab), given with platinum-doublet chemotherapy to patients with previously untreated advanced squamous non-small cell lung cancer. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login